RECENT ADVANCES IN THE TREATMENT OF SYSTEMIC MYCOTIC INFECTIONS
- 1 January 1979
- journal article
- review article
- Vol. 148 (3), 435-447
Abstract
Serious therapeutic problems are posed by the increasing incidence of invasive fungal infections in transplant recipients and in patients with compromised immune defenses, prosthetic devices and grafts and several other predisposing factors. A number of new approaches, including combination drug treatment and the development of newer agents, may justify increased optimism in the management of these infections.This publication has 38 references indexed in Scilit:
- FlucytosineAnnals of Internal Medicine, 1977
- Amphotericin B Induction of Sensitivity to Adriamycin, 1,3-bis (2-Chloroethyl)-1-Nitrosourea (BCNU) plus Cyclophosphamide in Human NeoplasiaAnnals of Internal Medicine, 1977
- Chronic Pulmonary Histoplasmosis: Improved Lymphocyte Response with Transfer FactorAnnals of Internal Medicine, 1976
- RECONSTITUTION OF DEFECTIVE CELLULAR IMMUNITY WITH FETAL THYMUS AND DIALYZABLE TRANSFER-FACTOR - LONG-TERM STUDIES IN A PATIENT WITH CHRONIC MUCOCUTANEOUS CANDIDIASIS1976
- CRYPTOCOCCOSIS AFTER RENAL-TRANSPLANTATION - REPORT OF 10 CASES1976
- SURVEY OF CURRENT STATUS OF CLINICAL USES OF ANTILYMPHOCYTE-SERUM1976
- Allergic Rash Due to Amphotericin BAnnals of Internal Medicine, 1976
- White Blood Cell Transfusions for Control of Infections in Neutropenic PatientsTransfusion, 1975
- Renal Tubular Acidosis Due to Amphotericin BNew England Journal of Medicine, 1968
- General Side EffectsAnnals of Internal Medicine, 1964